Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Change in Receivables (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Change in Receivables for 15 consecutive years, with -$532771.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables fell 315.79% to -$532771.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$547574.0, a 200.0% decrease, with the full-year FY2024 number at $659409.0, changed N/A from a year prior.
  • Change in Receivables was -$532771.0 for Q3 2025 at GeoVax Labs, up from -$964774.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $838136.0 in Q1 2025 to a low of -$964774.0 in Q2 2025.
  • A 4-year average of -$18266.3 and a median of $49763.0 in 2021 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: soared 127.66% in 2022, then crashed 420.87% in 2025.
  • GeoVax Labs' Change in Receivables stood at $49006.0 in 2021, then crashed by 303.09% to -$99526.0 in 2022, then skyrocketed by 212.37% to $111835.0 in 2024, then tumbled by 576.39% to -$532771.0 in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Change in Receivables are -$532771.0 (Q3 2025), -$964774.0 (Q2 2025), and $838136.0 (Q1 2025).